View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
February 17, 2020

Coronavirus Covid-19: China uses traditional medicine for treatment

China is reportedly using traditional medicine to treat patients with Covid-19 caused by the novel coronavirus, which emerged in the country in December last year.


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Free Whitepaper
img

What is the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry?

While wanting to protect the country from being overwhelmed by Omicron, China’s adherence to a Zero-COVID policy is resulting in a significant economic downturn. COVID outbreaks in Shanghai, Beijing and many other Chinese cities will impact 2022’s economic growth as consumers and businesses experience rolling lockdowns, leading to a slowdown in domestic and international supply chains. China’s Zero-COVID policy is having a demonstrable impact on consumer-facing industries. Access GlobalData’s new whitepaper, China in 2022: the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry, to examine the current situation in Shanghai and other cities in China, to better understand the worst-affected industry sectors, foodservice in particular, and to explore potential growth opportunities as China recovers. The white paper covers:
  • Which multinational companies have been affected?
  • What is the effect of lockdowns on foodservice?
  • What is the effect of lockdowns on Chinese ports?
  • Spotlight on Shanghai: what is the situation there?
  • How have Chinese consumers reacted?
  • How might the Chinese government react?
  • What are the potential growth opportunities?
by GlobalData
Enter your details here to receive your free Whitepaper.

Follow the latest updates of the outbreak on our timeline.

China is reportedly using traditional medicine to treat patients with Covid-19 caused by the novel coronavirus, which emerged in the country in December last year.

Hubei province health commission head Wang Hesheng said that treatment at Wuhan hospitals involves a combination of Traditional Chinese Medicine (TCM) and western drugs, reported Bloomberg.

At a press conference on 15 February, Hesheng added that TCM has been used to treat more than 50% of infected people in the province.

Hesheng was quoted by the news agency as saying: “Our efforts have shown some good result. Top TCM experts have been sent to Hubei for research and treatment.”

Covid-19 has so far claimed 1,775 lives and infected more than 71,000 people worldwide. The disease currently lacks a vaccine and effective treatments.

Companies and research teams are at work to develop vaccines and identify drugs that can target the new coronavirus.

Several clinical trials have already been launched in China to test if existing antiviral drugs, including Gilead’s remdesivir and AbbVie’s Kaletra, could help fight the epidemic.

Last week, researchers at the US National Institutes of Health (NIH) reported remdesivir was able to prevent a type of coronavirus, Middle East respiratory syndrome coronavirus (MERS-CoV), in monkeys.

 

Related Companies

Free Whitepaper
img

What is the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry?

While wanting to protect the country from being overwhelmed by Omicron, China’s adherence to a Zero-COVID policy is resulting in a significant economic downturn. COVID outbreaks in Shanghai, Beijing and many other Chinese cities will impact 2022’s economic growth as consumers and businesses experience rolling lockdowns, leading to a slowdown in domestic and international supply chains. China’s Zero-COVID policy is having a demonstrable impact on consumer-facing industries. Access GlobalData’s new whitepaper, China in 2022: the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry, to examine the current situation in Shanghai and other cities in China, to better understand the worst-affected industry sectors, foodservice in particular, and to explore potential growth opportunities as China recovers. The white paper covers:
  • Which multinational companies have been affected?
  • What is the effect of lockdowns on foodservice?
  • What is the effect of lockdowns on Chinese ports?
  • Spotlight on Shanghai: what is the situation there?
  • How have Chinese consumers reacted?
  • How might the Chinese government react?
  • What are the potential growth opportunities?
by GlobalData
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology